期刊文献+

人参多糖对K562细胞基因表达谱的影响 被引量:15

Effect of ginseng polysaccharide on gene expression profile of K562 cells
原文传递
导出
摘要 目的利用基因表达谱芯片研究人参多糖对体外培养的人红白血病K562细胞基因表达谱的影响。方法人参多糖处理K562细胞48 h后,分别提取给药组和对照组K562细胞总RNA,将两组RNA纯化为mRNA,逆转录成cDNA,用2种不同的荧光染料Cy3和Cy5进行线性扩增标记,与Illumina全基因组表达谱基因芯片杂交,采用生物信息学方法分析人参多糖处理后K562细胞基因表达谱的改变。结果共发现差异基因306个,其中上调基因220个,下调基因86个,并对其进行生物学功能分类。结论诱导肿瘤细胞分化是多基因作用的综合结果,筛选的基因对研究肿瘤发生、发展与逆转分化,以及寻找潜在的抗肿瘤药物作用靶点可能有意义。 Objective To investigate the effect of ginseng polysaccharide on the gene expression profile of human erythroleukemia K562 cells cultured in vitro.Methods The total RNAs treated with ginseng polysaccharide for 48 h were extracted from both K562 cells and the control K562 cells.All the RNAs were purified into mRNA and then convened to double-stranded cDNAs by reverse transcription.The cDNAs were labeled with a fluorescence dye Cy3 or Cy5 and hybridized to a Illumina whole-genome oligonucleotide microarray.The change in the gene expression profile of K562 cells following treatment with ginseng polysaccharide was analyzed by using bioinformatics.Results A total of 306 differential genes were found.Of which 220 were up-regulated and 86 were down-regulated.Their biologic function was classified.Conclusion Tumor cell differentiation is multiple genes comprehensive results,the screening of the genes may be meaningful for understanding tumorigenesis,tumor development,reverse polarization,and finding potential drug targets.
出处 《中草药》 CAS CSCD 北大核心 2011年第5期940-943,共4页 Chinese Traditional and Herbal Drugs
基金 国家自然科学基金资助项目(30873406)
关键词 人参多糖 K562细胞 基因表达谱 基因芯片 抗肿瘤 ginseng polysaccharide K562 cells gene expression profile gene chip antitumor
  • 相关文献

参考文献12

  • 1黎阳,张铁军,刘素香,陈常青.人参化学成分和药理研究进展[J].中草药,2009,40(1):164-164. 被引量:310
  • 2陈地龙,刘永刚,王亚平,陈婷梅,郑敏,姜蓉.人参多糖对K562细胞增殖抑制及诱导分化的实验研究[J].第三军医大学学报,2005,27(6):517-520. 被引量:25
  • 3陈地龙,李静,刘永刚,王亚平,陈婷梅,郑敏,姜蓉.人参多糖对K562细胞人粒-巨噬细胞集落刺激因子和促红细胞生成素及其受体表达的影响[J].中草药,2006,37(10):1526-1529. 被引量:2
  • 4Sebastian S, Kenkare U W. Expression of two type II-like tumour hexokinase RNA transcripts in cancer cell lines [J]. TumourBiol, 1998, 19(4): 253-260.
  • 5Aguayo A, Kantarjian H, Manshouri T, et al. Angiogenesis in acute and chronic leukemias and myelodysplastic syndromes [J]. Blood, 2000, 96(6): 2240-2245.
  • 6Lundberg L G, Lemer R, Sundelin P, et al. Bone marrow in ploycythemia vera, chronic myelocytic leukemia, and myelofibrosis has an increased vascularity [J]. Am J Pathol, 2000, 157(1): 15-19.
  • 7Wieczorek A J, Majka M, Curtis L M, et al. Bcr-ablpositive cells secrete angiogenic factors including matrix metalloproteinases and stimulate angiogenesis in vivo in matrigel implants [J]. Leukemia, 2002, 16(6): 1160-1166.
  • 8Stighall M, Manetopoulos C, Axelson H, et al. High ID2 protein expression correlates with a favourable prognosis in patients with primary breast cancer and reduces cellular invasiveness of breast cancer cells [J]. Int J Cancer, 2005, 115(3): 403-411.
  • 9Perk J, Iavarone A, Benezra R, et al. Id family of helix-loop-helix proteins in cancer [J]. Nat Rev Cancer, 2005, 5(8): 603-614.
  • 10Altenberger T, Bilban M, Auer M, et al. Identification of DLK1 variants in pituitary 2 and neur oendocrine tumors [J]. Biochem Biophys Res Commun, 2006, 340(3): 995-1005.

二级参考文献59

共引文献334

同被引文献229

引证文献15

二级引证文献244

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部